Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2024-09-04 Board/Management Inform…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Pacific Edge Chairman Delays Retirement 2 pages 108.1KB
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the delay of the Chairman's retirement and related board matters. It discusses the Board's request for the Chairman to remain in position to provide stability amid ongoing Medicare coverage uncertainty and recruitment of successors. There is no financial data, no detailed report, no voting results, no regulatory filing, and no mention of a report being attached or published. The content focuses on board and management changes and intentions, specifically about the Chairman and an Independent Director's retirement plans and recruitment process. This fits the category of Board/Management Information (MANG). The document length is 3556 characters, which is relatively short but contains substantive information about board changes rather than just an announcement of a report publication or regulatory filing. Therefore, the classification is MANG with high confidence.
2024-09-04 English
Notice of Annual Shareholders Meeting
AGM Information Classification · 95% confidence The document is a detailed notice for the 2024 Annual Shareholders Meeting of Pacific Edge Limited. It includes the meeting date, venue, agenda, resolutions to be voted on (including auditor re-appointment and director re-elections), explanatory notes, voting instructions, proxy information, and shareholder question procedures. It also references the Annual Report as a separate document available on the company's website and states that presentations will be released on the day of the meeting. The content is focused on the meeting logistics, shareholder voting, and board changes, which aligns with materials shared during an Annual General Meeting (AGM). There is no full financial report or detailed financial statements included, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a voting results announcement (DVA) since it is a notice prior to the meeting. Therefore, the document best fits the category of AGM Information (AGM-R). The document length and detail support a high confidence in this classification.
2024-08-15 English
Notice of Annual Shareholder Meeting and Proxy Form 2024 6 pages 643.8KB
AGM Information Classification · 95% confidence The document is a detailed notice for the 2024 Annual Shareholders Meeting (ASM) of Pacific Edge Limited. It includes the meeting date, venue, agenda, resolutions to be voted on (such as re-appointment of auditors and director re-elections), explanatory notes on resolutions, voting instructions, proxy information, and shareholder question procedures. It also references the Annual Report as a separate document available on the company's website, indicating this document is not the Annual Report itself. The content focuses on meeting logistics, shareholder voting, and board changes related to the meeting. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document is lengthy (15,000 characters) and contains substantive meeting details rather than just an announcement or a brief notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is AGM Information (AGM-R).
2024-08-14 English
Novitas Confirms Medicare Coverage Review Extension
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 29 July 2024 from Pacific Edge regarding an extension granted to Novitas, the Medicare Administrative Contractor, to finalize or withdraw a Local Coverage Determination (LCD) related to genetic testing for oncology. The content focuses on regulatory and reimbursement updates affecting the company's products, specifically Medicare coverage status and expected future updates. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (3493 characters) and serves as an update to shareholders and the public about ongoing regulatory developments rather than a full report or detailed financial disclosure. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a certification or officer attestation. It is not a voting result, capital change, or legal proceeding. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit more specific categories.
2024-07-28 English
Novitas Confirms Medicare Coverage Review Extension 2 pages 111.3KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 29 July 2024 from Pacific Edge regarding an extension granted by Novitas (a Medicare Administrative Contractor) to finalize or withdraw a Local Coverage Determination (LCD) related to genetic testing for oncology. The content focuses on regulatory and reimbursement updates affecting the company's products, specifically Medicare coverage status and expected future updates. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (3493 characters) and serves as an update to shareholders and the public about a regulatory matter impacting the company. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a certification or officer attestation. It is not a voting result, capital change, or legal proceeding. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit more specific categories.
2024-07-28 English
Medicare Coverage Determination Still Under Review
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 26 July 2024 from Pacific Edge regarding the status of Medicare coverage determination (LCD) for their genetic testing products. It discusses ongoing regulatory discussions and reimbursement status but does not contain financial statements, earnings data, or detailed financial analysis. The document is relatively short (3164 characters) and serves as an update to shareholders and the public about regulatory and reimbursement developments. It does not fit categories like Annual Report, Earnings Release, or Interim Report. It is not a report publication announcement since it does not mention a report being attached or published. The content is primarily a regulatory and reimbursement update, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-07-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.